These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 20962610

  • 21. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
    Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Atassi B, Baker T, Gates V, Miller FH, Sato KT, Wang E, Gupta R, Benson AB, Newman SB, Omary RA, Abecassis M, Kulik L.
    Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
    [Abstract] [Full Text] [Related]

  • 22. Is downstaging prior to liver transplantation important in hepatocellular carcinoma?
    Lee P, Kee S, Busuttil R.
    Am J Transplant; 2009 Aug; 9(8):1703-4. PubMed ID: 19660020
    [No Abstract] [Full Text] [Related]

  • 23. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.
    Gates VL, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, Nemcek AA, Omary R, Salem R.
    Future Oncol; 2007 Feb; 3(1):73-81. PubMed ID: 17280504
    [Abstract] [Full Text] [Related]

  • 24. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R, Seidensticker M, Peters N, Mohnike K, Bornschein J, Schütte K, Amthauer H, Malfertheiner P, Pech M, Ricke J.
    Dig Dis; 2009 Feb; 27(2):189-99. PubMed ID: 19546558
    [Abstract] [Full Text] [Related]

  • 25. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
    Rhee TK, Naik NK, Deng J, Atassi B, Mulcahy MF, Kulik LM, Ryu RK, Miller FH, Larson AC, Salem R, Omary RA.
    J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
    [Abstract] [Full Text] [Related]

  • 26. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.
    Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, Hunter RD, Nemcek AA, Abecassis MM, Haines KG, Salem R.
    J Surg Oncol; 2006 Dec 01; 94(7):572-86. PubMed ID: 17048240
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed?
    Volk M, Marrero JA.
    Gastroenterology; 2008 May 01; 134(5):1612-4. PubMed ID: 18471530
    [No Abstract] [Full Text] [Related]

  • 31. [Orthotopic liver transplantation and hepatocellular carcinoma].
    Gugenheim J, Crafa F, Iovine L, Fabiani P, Militerno G, Spampatti G, Goubaux B, Mouiel J.
    Minerva Chir; 1992 Nov 01; 47(21-22):1675-9. PubMed ID: 1336829
    [Abstract] [Full Text] [Related]

  • 32. Treatment of hepatocellular carcinoma.
    Bruix J.
    Hepatology; 1997 Feb 01; 25(2):259-62. PubMed ID: 9021931
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The forgotten place of radioembolization for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis.
    Levi Sandri GB, Lai Q, Lucatelli P.
    Liver Int; 2017 Mar 01; 37(3):469-470. PubMed ID: 27886440
    [No Abstract] [Full Text] [Related]

  • 35. Living-donor liver transplantation for hepatocellular carcinoma.
    Kawasaki S.
    Hepatogastroenterology; 2002 Mar 01; 49(43):53-5. PubMed ID: 11941984
    [Abstract] [Full Text] [Related]

  • 36. [Radioembolisation for hepatocellular carcinoma].
    Raoul JL, Edeline J, Pracht M, Boucher E, Rolland Y, Garin E.
    Cancer Radiother; 2011 Feb 01; 15(1):64-8. PubMed ID: 21236718
    [Abstract] [Full Text] [Related]

  • 37. Radioembolization with 90Y microspheres: technical considerations.
    Salem R.
    J Vasc Interv Radiol; 2007 Nov 01; 18(11):1460-1. PubMed ID: 18004003
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.